Nonsulfhydryl-reactive phenoxyacetic acids increase aqueous humor outflow facility

Investigative Ophthalmology and Visual Science

Volumn 38, Issue 8, 1997, Pages 1526-1534

  Epstein, David L ^a,b   Roberts, Bruce C ^a   Skinner, Laura L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

Ethacrynic acid; Indacrinone; Microtubules; Outflow facility; Ticrynafen

Indexed keywords

ETACRYNIC ACID; INDACRINONE; PACLITAXEL; PHENOXYACETIC ACID; THIOL DERIVATIVE; TIENILIC ACID; VINBLASTINE;

ANIMAL CELL; ANIMAL TISSUE; AQUEOUS HUMOR FLOW; ARTICLE; CATTLE; CONTROLLED STUDY; DRUG MECHANISM; GLAUCOMA; NONHUMAN; PRIORITY JOURNAL; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; SWINE; TRABECULAR MESHWORK;

ANIMALS; AQUEOUS HUMOR; CATTLE; CELLS, CULTURED; CYTOSKELETON; ENDOTHELIUM, VASCULAR; HUMANS; INDANS; PULMONARY ARTERY; SULFHYDRYL COMPOUNDS; SWINE; TICRYNAFEN; TRABECULAR MESHWORK; VINBLASTINE;

EID: 0030808051     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Epstein DL, Freddo TF, Bassett-Chu S, Chung M, Karageuzian L. Influence of ethacrynic acid on outflow facility in the monkey and calf eye. Invest Ophthalmol Vis Sci. 1987;28:2067-2075.
2. Liang L-L, Epstein DL, de Kater, AW, Shahsafaei A, Erickson-Lamy KA. Ethacrynic acid increases facility of outflow in the human eye in vitro. Arch Ophthalmol. 1992;110:106-109.
3. Tingey DP, Ozment RR, Schroeder A, Epstein DL. The effect of intracameral ethacrynic acid on the intraocular pressure of living monkeys. Am J Ophthalmol. 1992;113:706-711.
4. Epstein DL, Hooshmand LB, Epstein MPM. Thiol adducts of ethacrynic acid increase outflow facility in enucleated calf eyes. Curr Eye Res. 1992;11:253-258.
5. Tingey DP, Schroeder A, Epstein MPM, Epstein DL. Effects of topical ethacrynic acid adducts on intraocular pressure in rabbits and monkeys. Arch Ophthalmol. 1992;110:699-702.
6. Melamed S, Kotas-Neumann R, Barak A, Epstein DL. The effect of intracamerally injected ethacrynic acid on intraocular pressure in patients with glaucoma. Am J Ophthalmol. 1992;113:508-512.
7. Epstein DL. Will there be a remedy to reverse the changes in the trabecular meshwork and the optic nerve? A personal point-of-view on glaucoma therapy. J Glaucoma. 1993;2:138-140.
8. Croft MA, Hubbard WC, Kaufman PL. Effect of ethacrynic acid on aqueous outflow dynamics in monkeys. Invest Ophthalmol Vis Sci. 1994;35:1167-1175.
9. Wang R, Podos SM, Serle JB, Lee P, Neufeld AH, Deschenes R. Effects of topical ethacrynic acid ointment vs timolol on intraocular pressure in glaucomatous monkey eyes. Arch Ophthalmol. 1994;112:390-394.
10. Croft MA, Kaufman PL. Effect of daily topical ethacrynic acid on aqueous humor dynamics in monkeys. Curr Eye Res. 1995;14:777-781.
11. Erickson-Lamy KA, Schroeder A, Epstein DL. Ethacrynic acid induces reversible shape and cytoskeletal changes in cultured cells. Invest Ophthalmol Vis Sci. 1992;33:2631-2640.
12. Epstein DL, de Kater AW, Erickson-Lamy KA, Fay FS, Schroeder A, Hooshmand L. The search for a sulfhydryl drug for glaucoma: From chemistry to the cytoskeleton. In: Lütjen-Drecoll E, ed. Basic Aspects of Glaucoma Research III. New York, Stuttgart: Schattauer; 1993:345-353.
13. O'Brien ET, Perkins SL, Roberts BC, Epstein DL. Dexamethasone inhibits trabecular cell retraction. Exp Eye Res. 1996;62:675-688.
14. Schultz EM, Cragoe EJ, Bicking JB, Bolhofer WA, Sprague JM. Alpha, beta-unsaturated ketone derivatives of aryloxyacetic acids, a new class of diuretics. J Med Pharm Chem. 1962;5:660-662.
15. Edecrin (Ethacrynic Acid). In: Physicians' Desk Reference. 49th ed. Montvale, NJ: Medical Economics Data Production Company; 1995:1546-1548.
16. Epstein DL, Hashimoto JM, Anderson PJ, Grant WM. Effect of iodoacetamide perfusion on outflow facility and metabolism of the trabecular meshwork. Invest Ophthalmol Vis Sci. 1981;20:625-631.
17. Epstein DL, Patterson MM, Rivers SC, Anderson PJ. N-ethyl maleimide increases the facility of aqueous outflow in excised monkey and calf eyes. Invest Ophthalmol Vis Sci. 1982;22:752-756.
18. Lindenmayer JM, Kahn MG, Hertzmark E, Epstein DL. Morphology and function of the aqueous outflow system in monkey eyes perfused with sulfhydryl reagents. Invest Ophthalmol Vis Sci. 1983;24:710-717.
19. Kahn MG, Giblin FJ, Epstein DL. Glutathione in calf trabecular meshwork and its relation to aqueous humor outflow facility. Invest Ophthalmol Vis Sci. 1983;24:1283-1287.
20. Freddo TF, Patterson MM, Scott DR, Epstein DL. Influence of mercurial sulfhydryl agents on aqueous humor outflow pathways in enucleated eyes. Invest Ophthalmol Vis Sci. 1984;25:278-285.
21. Epstein DL, de Kater AW, Lou M, Patel J. Influences of glutathione and sulfhydryl containing compounds on aqueous humor outflow function. Exp Eye Res. 1990;50:785-794.
22. Weiner IM, Mudge GH. Diuretics and other agents employed in the mobilization of edema fluid. In: Gilman AG, Goodman LS, Rall TW, Murad F, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 7th ed. New York: Macmillan; 1985:903-904.
23. Dhamodharan R, Jordan MA, Thrower D, Wilson L, Wadsworth P. Vinblastine suppresses dynamics of individual microtubules in living interphase cells. Mol Biol Cell. 1995;6:1215-29.
24. Weber K, Rathke PC, Osborn M. Cytoplasmic microtubular images in glutaraldehyde fixed tissue culture cells by electron microscopy and by immunofluorescence microscopy. Proc Natl Acad Sci USA. 1978; 75:1820-1824.
25. Erickson-Lamy K, Epstein DL, Schroeder AM, Bassett-Chu S. Absence of time-dependent facility increase ('washout') in the perfused enucleated human eye. Invest Ophthalmol Vis Sci. 1990;31:2384-2388.
26. O'Brien ET, Roberts BC, Epstein DL. The role of cell-substrate junctions: Early changes in phosphotyrosination during induced changes in cell shape. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1995;36:S3362.
27. Burridge K, Fath K, Kelly T, Nuckolls G, Turner CE. Focal adhesions: Transmembrane junctions between the extracellular matrix and the cytoskeleton. Rev Cell Biol. 1988;4:487-525.
28. Burridge K, Turner CE, Romer LH. Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: A role in cytoskeletal assembly. J Cell Biol. 1992;119:893-903.
29. Xu S, Roychowdhury S, Gaskin F, Epstein DL. Ethacrynic acid inhibition of microtubule assembly in vitro. Arch Biochem Biophys. 1992;296:462-467.
30. Luduena RF, Roach MC, Epstein DL. The interaction of ethacrynic acid with bovine brain tubulin. Biochem Pharmacol. 1994;47:1677-1681.
31. Gurland G, Gundersen GG. Stable, detyrosinated microtubules function to localize vimentin intermediate filaments in fibroblasts. J Cell Biol. 1995;131:1275-1290.
32. Bhattacherjee P, Eakins KE. The intraocular pressure lowering effect of colchicine. Exp Eye Res. 1978;27: 649-653.
33. Ritch R, Mulberg A, Rosen C, Chubak G, Pokorny K, Yablonski M. The effect of colchicine on aqueous humor dynamics. Exp Eye Res. 1981;32:143-150.
34. Epstein DL, Rohen JW. Morphology of the trabecular meshwork and inner-wall endothelium after cationized ferritin perfusion in the monkey eye. Invest Ophthalmol Vis Sci. 1991;32:160-171.
35. Lacey ML, Haimo LT. Cytoplasmic dynein is a vesicle protein. J Biol Chem. 1992;267:4793-4798.
36. Ingber DE, Folkman J. Tension and compression as basic determinants of cell form and function: Utilization of a cellular tensegrity mechanism. In: Stein WD, Bonner F, eds. Cell Shape: Determinants, Regulation, and Regulatory Rale. San Diego: Academic Press; 1989: 3-31.
37. Heidemann SR, Buxbaum RB. Tension as a regulator and integrator of axonal growth. Cell Motil Cytoskeleton. 1990;17:6-10.
38. Gills JP, Roberts BC, Epstein DL. Microtubule disruption leads to active cellular contraction in human trabecular meshwork cells. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1996;37:53801.
39. Mitchison T, Kirschner M. Dynamic instability of microtubule growth. Nature. 1984;312:237-242.
40. Cassimeris L. Regulation of microtubule dynamic instability. Cell Motil Cytoskeleton. 1993;26:275-81.
41. Hamm-Alvarez SF, Kim PY, Sheetz MP. Regulation of vesicle transport in CV-1 cells and extracts. J Cell Sci. 1993;106:955-966.
42. Vallee RB, Sheetz MP. Targeting of motor proteins. Science. 1996;271:1539-1544.
43. Walker RA, O'Brien ET, Epstein DL, Sheetz MP. Treatment of kinesin with ethacrynic acid or n-ethyl maleimide inhibits kinesin microtubule binding. Mol Biol Cell. 1993;4:266a.
44. Cragoe E Jr. The (aryloxy) acetic acid family of diuretics. In: Cragoe E Jr, ed. Diuretics-Chemistry, Pharmacology, and Medicine. New York: John Wiley & Sons; 1983: 203-261.
45. Tumminia SF, Epstein DL, Tamm E, Russell P. The effects of mechanical stretch on signal transduction in human and rhesus monkey trabecular meshwork (TM) cells. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1996;37:S725.
46. O'Brien ET, Epstein DL. Observation of living glaucoma cells by video DIC microscopy. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1996;37:S4146.